ASK REDCHAT ANYTHING ABOUT ZYVERSA THERAPEUTICS INC.
ZyVersa Therapeutics Inc. (OTCQB: ZVSA)
Listen to this Section
$0.20
+0.0250
(
+14.29% )
13.8K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Cholesterol Efflux Mediator™ VAR 200DetailsDiabetic Kidney Disease |
Phase 2a |
Market Data
|
| Open |
$0.20 |
| Previous Close |
$0.18 |
| Volume |
13.8K |
| Market Cap |
$1.62M |
| Day Range |
$0.17 - $0.20 |
| 52 Week Range |
$0.11 - $1.67 |
| Shares Outstanding |
8.10M |
| Change % |
+14.29% |
| Net Change |
▲ 0.0250 |
| Insider Ownership |
N/A |
| Exchange |
OTCQB |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | |
| Country | United States |
| Underwriter | A.G.P., Brookline Capital Markets, more |
Insider Ownership Transactions
Total Amount Purchased:
-3,442.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-07-18 |
Sale |
-132.00 |
Freitag Gregory Gene |
| 2024-07-18 |
Sale |
-572.00 |
Cashmere Karen A. |
| 2024-07-18 |
Sale |
-132.00 |
Park Min-Chul |
| 2024-07-18 |
Sale |
-132.00 |
Finizio Robert G |
| 2024-07-18 |
Sale |
-132.00 |
SAPIRSTEIN JAMES |
| 2024-07-18 |
Sale |
-1627.00 |
Glover Stephen C. |
| 2024-07-18 |
Sale |
-715.00 |
Wolfe Peter |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 8-k |
8K-related |
12 |
Oct 15, 2025 |
| 8-k |
8K-related |
12 |
Sep 18, 2025 |
| 10-q |
Quarterly Reports |
53 |
Aug 13, 2025 |
| 8-k |
8K-related |
12 |
Jul 28, 2025 |
| 8-k |
8K-related |
12 |
Jul 16, 2025 |
| 4 |
Insider transactions |
1 |
Jul 16, 2025 |
| 4 |
Insider transactions |
1 |
Jul 15, 2025 |
| 4 |
Insider transactions |
1 |
Jul 15, 2025 |
| 4 |
Insider transactions |
1 |
Jul 15, 2025 |
| 4 |
Insider transactions |
1 |
Jul 15, 2025 |